These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5230213)

  • 21. [Becker's benign muscular dystrophy. Observations on 1 family].
    Armocida G; Cottini R; Finavera L; Majeron MA
    Minerva Med; 1978 May; 69(25):1745-8. PubMed ID: 662177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
    Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in the activity of blood serum enzymes in relatives of children with myopathy].
    Grinio LP
    Vopr Med Khim; 1966; 12(6):600-3. PubMed ID: 6000902
    [No Abstract]   [Full Text] [Related]  

  • 24. Ribosomal protein synthesis in Duchenne muscular dystrophy.
    Ionasescu V; Zellweger H; Conway TW
    Arch Biochem Biophys; 1971 May; 144(1):51-8. PubMed ID: 5117538
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigation on healthy individuals from families of patients with Duchenne type muscular dystrophy.
    Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Emeryk B; Wasowicz B; Slucka C; Hetnarska L; Bendarzewska B; Pucek Z
    Pol Med J; 1968; 7(1):228-37. PubMed ID: 5652928
    [No Abstract]   [Full Text] [Related]  

  • 26. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 27. MUSCULAR DYSTROPHY.
    BENNETT BM; NAKAMURA E
    Br Med J; 1964 Jul; 2(5402):139-40. PubMed ID: 14150884
    [No Abstract]   [Full Text] [Related]  

  • 28. [On Becker's benign muscular dystrophy: study of a family with 10 affected members in 6 generations].
    Caruso G; Campanella G
    Acta Neurol (Napoli); 1968; 23(4):709-31. PubMed ID: 5747395
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinico-statistical considerations on a group of 22 patients with progressive muscular dystrophy].
    Garofalo E; Marcer V
    Fracastoro; 1966; 59(6):621-38. PubMed ID: 5998705
    [No Abstract]   [Full Text] [Related]  

  • 31. [Differentiation and dedifferentiation of muscular dystrophy].
    Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K
    Nihon Rinsho; 1968 Oct; 26(10):2423-42. PubMed ID: 5752013
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical studies in progressive muscular dystrophy].
    Prot J
    Neurol Neurochir Pol; 1971; 5(4):473-8. PubMed ID: 5122052
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum enzyme changes in muscle disease and their relation to tissue change.
    HUGHES BP
    Proc R Soc Med; 1963 Mar; 56(3):179-82. PubMed ID: 13955533
    [No Abstract]   [Full Text] [Related]  

  • 34. [Contribution to the study of the enzymology of primary myopathies of childhood].
    Vitetta M
    Biol Lat; 1965; 18(4):359-66. PubMed ID: 5871253
    [No Abstract]   [Full Text] [Related]  

  • 35. [Plasma level of hemopexin (Hpx) in families with progressive muscular dystrophy (PMD)].
    Diotallevi P; Balducci E; Canapa A; Danni M; Giamagli CA; Lucesoli S; Ravaglia P; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):531-8. PubMed ID: 3190906
    [No Abstract]   [Full Text] [Related]  

  • 36. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biological anomalies in the apparently healthy transmitters of muscular dystrophy].
    DEMOS J; DREYFUS JC; SCHAPIRA F; SCHAPIRA G
    Rev Can Biol; 1962; 21():587-97. PubMed ID: 14026924
    [No Abstract]   [Full Text] [Related]  

  • 38. Myoglobin is a sensitive marker of increased muscle membrane vulnerability.
    Driessen-Kletter MF; Amelink GJ; Bär PR; van Gijn J
    J Neurol; 1990 Jul; 237(4):234-8. PubMed ID: 2391544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 40. PLASMA CREATINE KINASE ACTIVITY IN MICE WITH HEREDITARY MUSCULAR DYSTROPHY.
    HOSENFELD DJ; WIESMANN U; RICHTERICH R
    Enzymol Biol Clin (Basel); 1962-1963; 16():246-9. PubMed ID: 14043838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.